Products

Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Okadaic Acid (DSP) ELISA Kit-Competitive

Product Overview

BioVenic Okadaic Acid (DSP) ELISA Kit-Competitive is designed for the quantitative determination of Okadaic Acid in water, shellfish and other samples using a Competitive ELISA method. For research use only.

Specifications

Assay Type ELISA-Competitive

Specificity The assay kit is specific for Okadaic Acid.

Target Species General

Species Reactivity General

Assay Time Around 60 min

Sample Requirement Water and shellfish. For special sample types, contact us for more information.

Target Information

Diarrheic shellfish poisoning (DSP) is one of the four known types of shellfish poisoning, primarily presenting as diarrhea. It can also cause abdominal pain, nausea, and vomiting. The toxins responsible, Okadaic Acid (OA) and its analogs (DTX-1, DTX-2, and DTX-3), are acid polyethers that bind to the receptor site of serine/threonine protein phosphatases, inhibiting their activity and leading to a rapid increase in phosphorylated proteins. These toxins are the sole components of the DSP complex that induce diarrheagenic effects in mammals.

Target/Biomarker Okadaic Acid

Target Synonym Okadaic Acid; DSP; diarrhetic shellfish toxins; DSTs

Shipping and Storage

This product is shipped with gel ice packs. It is recommended to store at 2-8°C.

Documents

Datasheet

COA

To request a Certificate of Analysis, please enter the Lot No. in the search box. Note: Certificate of Analysis not available for kits.

The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.

References

Eberhart, Bich-Thuy L., et al. "Screening tests for the rapid detection of diarrhetic shellfish toxins in Washington State." Marine drugs 11.10 (2013): 3718-3734.